Hypothesis

3 Matching Annotations

Oct 2026
www.sciencedirect.com www.sciencedirect.com

Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma

1
1. scibot 15 Oct 2026
  
  in Public
  
  RRID: CVCL_1341
  
  DOI: 10.1016/j.celrep.2026.117997
  
  Resource: (JCRB Cat# IFO50431, RRID:CVCL_1341)
  
  Curator: @nmaralla
  
  SciCrunch record: RRID:CVCL_1341
  
  What is this?
  
  RRID:CVCL_1341
Visit annotations in context

Tags

RRID:CVCL_1341

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124726010752
Dec 2024
www.sciencedirect.com www.sciencedirect.com

T-Switch: A specificity-based engineering platform for developing safe and effective T cell therapeutics

1
1. scibot 05 Dec 2024
  
  in Public
  
  XenoTechIFO50431
  
  DOI: 10.1016/j.immuni.2024.11.009
  
  Resource: (JCRB Cat# IFO50431, RRID:CVCL_1341)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1341
  
  What is this?
  
  RRID:CVCL_1341
Visit annotations in context

Tags

RRID:CVCL_1341

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761324005247
Nov 2022
www.sciencedirect.com www.sciencedirect.com

YM155 Inhibits Neuroblastoma Growth through Degradation of MYCN: A New Role as a USP7 Inhibitor

1
1. scibot 29 Nov 2022
  
  in Public
  
  RRID: CVCL_1341
  
  DOI: 10.1016/j.ejps.2022.106343
  
  Resource: (JCRB Cat# IFO50431, RRID:CVCL_1341)
  
  Curator: @a5munoz
  
  SciCrunch record: RRID:CVCL_1341
  
  What is this?
  
  RRID:CVCL_1341
Visit annotations in context

Tags

RRID:CVCL_1341

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0928098722002287